Founder Yusuf Henriques and Chief Scientific Officer Bradford Wilson, PhD, have combined their experience at the FDA, in the military, and in academia to drive the development of therapeutics that are effective in underrepresented populations. — Challenge While COVID-19 was devastating across the globe, it was particularly damaging for communities of color. African American, Latino, and Native American populations experienced disproportionately higher rates of infection and death than their European-American counterparts during the pandemic. This was in part due to underlying inequities in healthcare and increased exposure…